-
Economic evaluation of nivolumab combined with ipilimumab in the first-line t...
The objective of this study was to evaluate the cost-effectiveness of nivolumab in combination with ipilimumab (nivo + ipi) compared to current therapeutic alternatives in... -
dedup_wf_001--7461e22ba55f012f42ded7c8480fb3eb
OBJECTIVES: Genomic profiling in oncology is vital for determining eligible patients for mutation-specific targeted therapies. Use of commercial genomic testing has the... -
Societal implications of medical insurance coverage for imatinib as first-lin...
Objectives: Imatinib (Glivec) and nilotinib (Tasigna) have been covered by critical disease insurance in Jiangsu province of China since 2013, which changed local treatment... -
Cost-effectiveness and budget impact analysis of infliximab and its biosimila...
This study aimed to conduct a cost-effectiveness analysis of infliximab and its biosimilar compared to conventional therapy in refractory moderate-to-severe Crohn’s disease (CD)... -
Cost utility analysis of tisagenlecleucel vs salvage chemotherapy in the trea...
Background: Patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL) have limited treatment options and poor prognoses. Tisagenlecleucel, a chimeric... -
Carbon footprint of school lunch menus adhering to the Spanish dietary guidel...
Current eating patterns are damaging the environment and there is a need for dietary guidelines to address this issue. Schools can act as springboards to promote sustainable... -
Budget impact analysis of betrixaban for venous thromboembolism prophylaxis i...
Objectives: Venous thromboembolism (VTE) incurs substantial costs to the UK National Health Service (NHS). Betrixaban is approved in the US for VTE prophylaxis with a... -
Interprofessional practice in health: A qualitative study in psychologists, e...
Chronic diseases are complex conditions requiring a range of health professionals to support lifestyle behavior change, with research indicating that interprofessional teams...
